CBRE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CBRE Group Inc is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has strong industry positioning and growth potential, the mixed financial performance, bearish technical indicators, and lack of immediate positive catalysts suggest holding off on investment until clearer signals emerge.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral at 49.068, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 134.358, with key resistance at 137.657 and support at 131.06. Overall, the technical indicators suggest a cautious outlook.
Hedge funds are increasing their positions, with a 113.38% increase in buying activity last quarter.
Analysts at UBS and Goldman Sachs have recently upgraded the stock or maintained a Buy rating, citing strong industry trends and CBRE's positioning to benefit from AI and data assets.
The company anticipates strong revenue and earnings growth for 2026 (10.8% and 15.4%, respectively).
Recent financial performance shows declining net income (-14.58% YoY), EPS (-12.03% YoY), and gross margin (-10.77% YoY).
The broader real estate operations sector faces challenges due to geopolitical instability and macroeconomic uncertainties.
Analysts have lowered price targets recently, citing weaker investor sentiment in the commercial real estate sector.
In Q4 2025, CBRE reported revenue growth of 11.77% YoY to $11.63 billion. However, net income dropped by 14.58% YoY to $416 million, EPS fell by 12.03% YoY to $1.39, and gross margin declined by 10.77% YoY to 16.91%. This mixed performance reflects growth in revenue but challenges in profitability.
Analyst sentiment is cautiously optimistic. UBS upgraded the stock to Buy, citing a rare buying opportunity and strong industry trends. Goldman Sachs maintained a Buy rating, highlighting limited AI disruption risks. However, Barclays and Keefe Bruyette lowered their price targets, citing weaker investor sentiment and sector challenges.
